Testing effectiveness (Phase 2)Not Yet RecruitingNCT07621497
What this trial is testing
FOLFOX8 Versus mFOLFOX6 With Bevacizumab or Cetuximab for First-Line Unresectable Metastatic Colorectal Cancer (Phase II)
Who this might be right for
Metastatic Colorectal Cancer (CRC)
Sun Yat-sen University 229